Show simple item record

AuthorAgrahari, Ashish Kumar
AuthorSneha, P
AuthorGeorge Priya Doss, C
AuthorSiva, R
AuthorZayed, Hatem
Available date2018-02-05T10:00:48Z
Publication Date2017-10-01
Publication NameMetabolic Brain Diseaseen_US
Identifierhttp://dx.doi.org/10.1007/s11011-017-0121-2
CitationAgrahari, A.K., Sneha, P., George Priya Doss, C. et al. Metab Brain Dis (2017). https://doi.org/10.1007/s11011-017-0121-2
ISSN0885-7490
URIhttp://hdl.handle.net/10576/6210
AbstractCharcot-Marie-Tooth disease (CMT) is one of the most commonly inherited congenital neurological disorders, affecting approximately 1 in 2500 in the US. About 80 genes were found to be in association with CMT. The phosphoribosyl pyrophosphate synthetase 1 (PRPS1) is an essential enzyme in the primary stage of de novo and salvage nucleotide synthesis. The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer. In the present study, we obtained 20 missense mutations from UniProt and dbSNP databases and applied series of comprehensive in silico prediction methods to assess the degree of pathogenicity and stability. In silico tools predicted four missense mutations (D52H, M115 T, L152P, and D203H) to be potential disease causing mutations. We further subjected the four mutations along with native protein to 50 ns molecular dynamics simulation (MDS) using Gromacs package. The resulting trajectory files were analyzed to understand the stability differences caused by the mutations. We used the Root Mean Square Deviation (RMSD), Radius of Gyration (Rg), solvent accessibility surface area (SASA), Covariance matrix, Principal Component Analysis (PCA), Free Energy Landscape (FEL), and secondary structure analysis to assess the structural changes in the protein upon mutation. Our study suggests that the four mutations might affect the PRPS1 protein function and stability of the structure. The proposed study may serve as a platform for drug repositioning and personalized medicine for diseases that are caused by the PRPS1 deficiency.
Languageen
PublisherSpringer Verlag
SubjectCMTX5
SubjectMissense mutations
SubjectMolecular dynamics simulation
SubjectPRPS1
SubjectPathogenicity
SubjectStability
TitleA profound computational study to prioritize the disease-causing mutations in PRPS1 gene.
TypeArticle
Pagination1 - 12
ESSN1573-7365


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record